Embrace challenges and move forward with resilience.
Viral vectors are modified viruses that can carry and deliver genes into target cells and animals. During the virus packaging process, the desired genetic material is inserted into the viral vector, which is then propagated in host cells to produce a high quantity of the modified virus. The resulting viral particles can then be used to deliver the genetic material into specific cells or tissues for various purposes, such as gene therapy or genetic engineering.
Virus packaging plays a crucial role in gene delivery as it allows researchers to use viruses as vehicles to introduce specific genes into cells and tissues, thereby manipulating their genetic makeup or function. This technique has significant applications in biomedical research, including the development of therapeutic treatments for genetic disorders and the study of cellular processes and disease mechanisms.
Hanbio was founded in 2010 and is a high-tech enterprise focused on gene technology research and application transformation, located in Shanghai China. Hanbio has always been committed to the research and production of gene vectors, and our core competitive products include lentiviruses, adenoviruses, and adeno-associated viruses. At the same time, we focus on hot topics, including autophagy flow research tools, virus vector based CRISPR gene editing tools, non-coding RNA, and luciferase experiments.
In the future, we will focus more on the application of core gene technology in clinical transformation.
Embrace challenges and move forward with resilience.
Innovate in gene technology. Drive scientific milestones.
Delivering excellent solutions for pharmaceutical research and making outstanding contributions to global health.
Committing to excellence in quality. Supporting scientific research wholeheartedly.
Positive Feedback
User Citations
Client Projects Annual
Project Experiences